Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the...
46 insider purchases on record · latest filing 2026-03-11.
Insiders have also filed 7 sale transactions at EDSA.